Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Aug 24 2018

Full Issue

Teens See Benzos As Safer Than Opioids, But The Anti-Anxiety Meds Can Be Just As Deadly And Harder To Kick

Addiction specialists say that they're seeing a sharp upswing in teens abusing benzodiazepines, which can cause seizures during withdrawal. "We see things first. So, I’m not surprised that the spike in Xanax use isn’t reflected in national data yet," said Sharon Levy, director of adolescent addiction treatment at Boston Children’s Hospital. “When I ask them if they’re using opioids, they say, ‘No. I wouldn’t touch the stuff.’” News on addiction and the opioid crisis also comes out of Louisiana, Wisconsin and Arizona -- and was a topic of discussion on this week's "What The Health" podcast.

Stateline: Teen Xanax Abuse Is Surging

This school year, addiction specialists say they’re expecting an onslaught of teens addicted to Xanax and other sedatives in a class of anti-anxiety drugs known as benzodiazepines, or “benzos.” Many teens view Xanax as a safer and more plentiful alternative to prescription opioids and heroin — with similar euphoric effects. But addiction experts warn that the pills kids are taking, often found in their parents’ or grandparents’ medicine cabinets, can be just as deadly as opioids, especially when taken in combination with other drugs or alcohol. And it’s much harder to kick the habit. (Vestal, 8/24)

New Orleans Times-Picayune: How Do You Recognize An Opioid Overdose? City Offers Free Training Starting Thursday 

The New Orleans Heath Department is hosting a series of opioid overdose prevention trainings for the community starting Thursday evening (Aug. 23). The first training session will take place from 6-7:30 p.m. at the Norman Mayer Library, 3001 Gentilly Blvd. The event will cover facts and statistics about the opioid crisis in New Orleans as well as instruction on how to recognize an overdose, how to obtain and use naloxone, and how to find treatment options in the city. The trainings are free and open to the public. (Clark, 8/23)

Milwaukee Journal Sentinel: Wisconsin Pharmacies Unclear On Narcan Laws To Reduce Opioid Overdoses

A lifesaving drug that can reverse a heroin or opioid overdose should be easily available at pharmacies across Wisconsin. But a survey of more than 450 pharmacies in the state turned up conflicting guidance from staff members when asked how to purchase naloxone, known by its brand name Narcan. (Luthern, 8/23)

Arizona Republic: Tucson Medical Center Sues Opioid Manufacturers Due To Overdose Costs

Citing the increasingly high cost of treating patients who suffer an opioid overdose, an Arizona hospital is suing more than two dozen pharmaceutical companies. Tucson Medical Center on Wednesday sued Johnson & Johnson, Abbott Laboratories, Cephalon Inc. and Purdue Pharma, among other manufacturers and distributors of opioids. (Innes, 8/23)

Kaiser Health News: Podcast: KHN’s ‘What The Health?’ Opioids, EpiPens And Health Funding 

The Senate is still working, well into August – something it hasn’t done in years — and it’s debating the funding bill for the Department of Health and Human Services. There is a back-to-school shortage of EpiPens, needed by people with severe allergies to treat potentially life-threatening reactions, and the Food and Drug Administration is weighing in. And “reinsurance” is back in the picture. The Trump administration has granted permission for New Jersey and Maryland to create such programs aimed at helping bring down premiums in the individual insurance market by helping pay for the most expensive enrollees. (8/23)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF